Post-translational Modification of LipL32 during Leptospira interrogans Infection

PLoS Neglected Tropical Diseases

Volumn 8, Issue 10, 2014, Pages

  Witchell, Timothy D ^a   Eshghi, Azad ^a   Nally, Jarlath E ^b   Hof, Rebecca ^a   Boulanger, Martin J ^a   Wunder, Elsio A ^c,d   Ko, Albert I ^c,d   Haake, David A ^e,f   Cameron, Caroline E ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c YALE UNIVERSITY   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EPITOPE; LYSINE; OUTER MEMBRANE PROTEIN LIPL32; ANTISERUM; LIPL32 PROTEIN, LEPTOSPIRA; LIPOPROTEIN; OUTER MEMBRANE PROTEIN;

ACETYLATION; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MALE; MASS FRAGMENTOGRAPHY; METHYLATION; NONHUMAN; PEPTIDE MAPPING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; WISTAR RAT; ZOONOSIS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; HUMANS; IMMUNE EVASION; IMMUNE SERA; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LIPOPROTEINS; MALE; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; ZOONOSES;

EID: 84920545870     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003280     Document Type: Article

References (53)

1. Faine S, Adler B, Bolin C, Perolat P (1999) Leptospira and leptospirosis. 2nd ed. Melbourne: MediSci. 272 p.
2. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, et al. (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757–771.
3. Ko AI, Goarant C, Picardeau M, (2009) Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 7: 736–747 DOI:10.1038/nrmicro2208
4. Evangelista KV, Coburn J, (2010) Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol 5: 1413–1425 DOI:10.2217/fmb.10.102
5. Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD, JrRiley LW, (1999) Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354: 820–825.
6. Maciel EAP, de Carvalho ALF, Nascimento SF, de Matos RB, Gouveia EL, et al. (2008) Household transmission of Leptospira infection in urban slum communities. PLoS Negl Trop Dis 2: e154 DOI:10.1371/journal.pntd.0000154
7. Reis RB, Ribeiro GS, Felzemburgh RDM, Santana FS, Mohr S, et al. (2008) Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2: e228 DOI:10.1371/journal.pntd.0000228
8. Hartskeerl RA, Collares-Pereira M, Ellis WA, (2011) Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17: 494–501 DOI:10.1111/j.1469-0691.2011.03474.x
9. UN Habitat (2003) The challenge of slums - global report on human settlements 2003. London: Earthscan Publications Ltd. 310 p.
10. Ido Y, Hoki R, Ito H, Wani H, (1917) The rat as a carrier of Spirochaeta icterohaemorrhagiae, the causative agent of Weil's disease (spirochaetosis icterohaemorrhagica). J Exp Med 26: 341–353.
11. Tucunduva de Faria M, Athanazio DA, Gonçalves Ramos EA, Silva EF, Reis MG, et al. (2007) Morphological alterations in the kidney of rats with natural and experimental Leptospira infection. J Comp Pathol 137: 231–238 DOI:10.1016/j.jcpa.2007.08.001
12. Monahan AM, Callanan JJ, Nally JE, (2008) Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun 76: 4952–4958 DOI:10.1128/IAI.00511-08
13. Izurieta R, Galwankar S, Clem A, (2008) Leptospirosis: The “mysterious” mimic. J Emerg Trauma Shock 1: 21–33 DOI:10.4103/0974-2700.40573
14. Plank R, Dean D, (2000) Overview of the epidemiology, microbiology, and pathogenesis of Leptospira in humans. Microbes Infect 2: 1265–1276.
15. Ganoza CA, Matthias MA, Saito M, Cespedes M, Gotuzzo E, et al. (2010) Asymptomatic renal colonization of humans in the Peruvian Amazon by Leptospira. PLoS Negl Trop Dis 4: e612 DOI:10.1371/journal.pntd.0000612
16. Levett PN, (2001) Leptospirosis. Clin Microbiol Rev 14: 296–326 DOI:10.1128/CMR.14.2.296-326.2001
17. Eshghi A, Pinne M, Haake DA, Zuerner RL, Frank A, et al. (2012) Methylation and in vivo expression of the surface-exposed Leptospira interrogans outer-membrane protein OmpL32. Microbiol Read Engl 158: 622–635 DOI:10.1099/mic.0.054767-0
18. Cao X-J, Dai J, Xu H, Nie S, Chang X, et al. (2010) High-coverage proteome analysis reveals the first insight of protein modification systems in the pathogenic spirochete Leptospira interrogans. Cell Res 20: 197–210 DOI:10.1038/cr.2009.127
19. Chao C-C, Zhang Z, Wang H, Alkhalil A, Ching W-M, (2008) Serological reactivity and biochemical characterization of methylated and unmethylated forms of a recombinant protein fragment derived from outer membrane protein B of Rickettsia typhi. Clin Vaccine Immunol CVI 15: 684–690 DOI:10.1128/CVI.00281-07
20. Rodionov AV, Eremeeva ME, Balayeva NM, (1991) Isolation and partial characterization of the M(r) 100 kD protein from Rickettsia prowazekii strains of different virulence. Acta Virol 35: 557–565.
21. Zhang J, Hao J, Walker DH, Yu X, (2006) A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir. Vaccine 24: 2317–2323 DOI:10.1016/j.vaccine.2005.11.044
22. Chao C-C, Chelius D, Zhang T, Mutumanje E, Ching W-M, (2007) Insight into the virulence of Rickettsia prowazekii by proteomic analysis and comparison with an avirulent strain. Biochim Biophys Acta 1774: 373–381 DOI:10.1016/j.bbapap.2007.01.001
23. Bechah Y, El Karkouri K, Mediannikov O, Leroy Q, Pelletier N, et al. (2010) Genomic, proteomic, and transcriptomic analysis of virulent and avirulent Rickettsia prowazekii reveals its adaptive mutation capabilities. Genome Res 20: 655–663 DOI:10.1101/gr.103564.109
24. Abeykoon A, Wang G, Chao C-C, Chock PB, Gucek M, et al. (2014) Multimethylation of Rickettsia OmpB catalyzed by lysine methyltransferases. J Biol Chem 289: 7691–7701 DOI:10.1074/jbc.M113.535567
25. Malmstrom J, Beck Martin, Schmidt A, Lange V, Deutsch EW, et al. (2009) Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 460: 762–765 DOI:10.1038/nature08184
26. Silva JJP, Dalston MO, Carvalho JEM, Setúbal S, Oliveira JMC, et al. (2002) Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 35: 395–399.
27. Nally JE, Chantranuwat C, Wu X-Y, Fishbein MC, Pereira MM, et al. (2004) Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 164: 1115–1127 DOI:10.1016/S0002-9440(10)63198-7
28. Ellinghausen HC, JrMcCullough WG, (1965) Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am J Vet Res 26: 45–51.
29. Johnson RC, Harris VG, (1967) Differentiation of pathogenic and saprophytic letospires. I. Growth at low temperatures. J Bacteriol 94: 27–31.
30. Nally JE, Whitelegge JP, Aguilera R, Pereira MM, Blanco DR, et al. (2005) Purification and proteomic analysis of outer membrane vesicles from a clinical isolate of Leptospira interrogans serovar Copenhageni. Proteomics 5: 144–152 DOI:10.1002/pmic.200400880
31. Nally JE, Whitelegge JP, Bassilian S, Blanco DR, Lovett MA, (2007) Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun 75: 766–773 DOI:10.1128/IAI.00741-06
32. Haake DA, Matsunaga J, (2002) Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun 70: 4936–4945.
33. Nally JE, Monahan AM, Miller IS, Bonilla-Santiago R, Souda P, et al. (2011) Comparative proteomic analysis of differentially expressed proteins in the urine of reservoir hosts of leptospirosis. PLoS One 6: e26046 DOI:10.1371/journal.pone.0026046
34. Matthiesen R, Trelle MB, Højrup P, Bunkenborg J, Jensen ON, (2005) VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins. J Proteome Res 4: 2338–2347 DOI:10.1021/pr050264q
35. Zhang K, Yau PM, Chandrasekhar B, New R, Kondrat R, et al. (2004) Differentiation between peptides containing acetylated or tri-methylated lysines by mass spectrometry: an application for determining lysine 9 acetylation and methylation of histone H3. Proteomics 4: 1–10 DOI:10.1002/pmic.200300503
36. Lottersberger J, Guerrero SA, Tonarelli GG, Frank R, Tarabla H, et al. (2009) Epitope mapping of pathogenic Leptospira LipL32. Lett Appl Microbiol 49: 641–645 DOI:10.1111/j.1472-765X.2009.02723.x
37. Cameron CE, Brouwer NL, Tisch LM, Kuroiwa JMY, (2005) Defining the interaction of the Treponema pallidum adhesin Tp0751 with laminin. Infect Immun 73: 7485–7494 DOI:10.1128/IAI.73.11.7485-7494.2005
38. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, et al. (2000) The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 68: 2276–2285.
39. Tung J-Y, Yang C-W, Chou S-W, Lin C-C, Sun Y-J, (2010) Calcium binds to LipL32, a lipoprotein from pathogenic Leptospira, and modulates fibronectin binding. J Biol Chem 285: 3245–3252 DOI:10.1074/jbc.M109.006320
40. Vivian JP, Beddoe T, McAlister AD, Wilce MCJ, Zaker-Tabrizi L, et al. (2009) Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira . J Mol Biol 387: 1229–1238 DOI:10.1016/j.jmb.2009.02.038
41. Pustelny C, Brouwer S, Müsken M, Bielecka A, Dötsch A, et al. (2013) The peptide chain release factor methyltransferase PrmC is essential for pathogenicity and environmental adaptation of Pseudomonas aeruginosa PA14. Environ Microbiol 15: 597–609 DOI: 10.1111/1462-2920.12040
42. Hauk P, Macedo F, Romero EC, Vasconcellos SA, de Morais ZM, et al. (2008) In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun 76: 2642–2650 DOI:10.1128/IAI.01639-07
43. Hauk P, Guzzo CR, Roman Ramos H, Ho PL, Farah CS, (2009) Structure and calcium-binding activity of LipL32, the major surface antigen of pathogenic Leptospira sp. J Mol Biol 390: 722–736 DOI:10.1016/j.jmb.2009.05.034
44. Lo Y-Y, Hsu S-H, Ko Y-C, Hung C-C, Chang M-Y, et al. (2013) Essential calcium-binding cluster of Leptospira LipL32 protein for inflammatory responses through the Toll-like receptor 2 pathway. J Biol Chem 288: 12335–12344 DOI:10.1074/jbc.M112.418699
45. Hauk P, Barbosa AS, Ho PL, Farah CS, (2012) Calcium binding to Leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J Biol Chem 287: 4826–4834 DOI:10.1074/jbc.M111.277210
46. Pinne M, Haake DA, (2013) LipL32 is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS One 8: e51025 DOI:10.1371/journal.pone.0051025
47. Murray GL, Srikram A, Hoke DE, Wunder EA, JrHenry R, et al. (2009) Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun 77: 952–958 DOI:10.1128/IAI.01370-08
48. Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, et al. (2001) Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol 39: 3303–3310.
49. Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, et al. (2001) Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun 69: 4958–4968 DOI:10.1128/IAI.69.8.4958-4968.2001
50. Engelhard VH, Altrich-Vanlith M, Ostankovitch M, Zarling AL, (2006) Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol 18: 92–97 DOI:10.1016/j.coi.2005.11.015
51. Doyle HA, Mamula MJ, (2012) Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol 24: 112–118 DOI:10.1016/j.coi.2011.12.003
52. Deveson Lucas DS, Lo M, Bulach DM, Quinsey NS, Murray GL, et al. (2014) Recombinant LipL32 stimulates interferon-gamma production in cattle vaccinated with a monovalent Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis vaccine. Vet Microbiol 169: 163–170 DOI:10.1016/j.vetmic.2013.12.016
53. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, et al. (2007) Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26: 88–95 DOI:10.1016/j.vaccine.2007.10.052